NEUP

2.3501.29%
AH

Adrian Hinton

Financial Controller

Mr. Adrian Hinton, BEc, FCA, has been Financial Controller of Neuphoria Therapeutics Inc. (formerly known as Bionomics Limited) since July 01, 2023. He served as Acting Chief Financial Officer of Neuphoria Therapeutics Inc. (formerly known as Bionomics Limited) since May 03, 2019 until July 01, 2023 and served as its Interim Company Secretary since March 2021 until April 08, 2021. Mr. Hinton has served as an accounting consultant for various companies since July 2018. Mr. Hinton has had a long career with Deloitte (Adelaide) from January 1975 to July 2018, retiring 1 July 2018 as Principle in the Audit and Assurance Group. He was responsible for managing the audit services to various Adelaide based public and private companies. His experience has given a broad-based knowledge of contemporary accounting and audit issues inclusive of experience in working with a wide range of clients in different industries, from listed entities, private corporations to major subsidiaries of multinational listed companies, covering consumer, agriculture, retail, manufacturing, automotive, biopharmaceutical and resources sectors. Mr. Hinton also has experience in preparing due diligence reviews, investigative accounting reports and the review of profit forecasts. Mr. Hinton has served on the Board of the Multiple Sclerosis Society of South Australia and Northern Territory Inc. since November 2016, Carers Association of SA Inc. since May 2019 and Australian PNG Alliance Group Pty Ltd. since October 2018. Mr. Hinton also volunteers his time and skill set to aiding community groups both locally and internationally. Mr. Hinton received his Bachelor?s degree in economics from the University of Adelaide, Australia and is a Fellow of the Chartered Accounts Australia and New Zealand.

Positions